CVR number 37576492
Industry 26.6010 Manufacture of irradiation, electromedical and electrotherapeutic equipment

Advanced Bionics Denmark ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/3
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
Bankruptcy risk for industry  2.3% 2.3% 2.3% 2.3% 2.3%  
Bankruptcy risk  4.6% 4.9% 1.6% 1.0% 1.6%  
Credit score (0-100)  47 44 73 85 73  
Credit rating  BBB BBB A A A  
Credit limit (kDKK)  0.0 0.0 11.2 272.8 10.3  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/3
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
Net sales  0 0 0 0 0  
Gross profit  4,867 5,724 8,076 4,476 4,429  
EBITDA  789 468 4,590 326 63.1  
EBIT  734 420 4,535 284 35.5  
Pre-tax profit (PTP)  733.7 419.9 4,534.9 283.4 35.4  
Net earnings  567.7 327.2 3,536.2 448.6 -136.8  
Pre-tax profit without non-rec. items  734 420 4,535 283 35.4  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/3
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
Tangible assets total  90.2 68.0 112 45.2 96.2  
Shareholders equity total  338 665 4,202 4,650 4,513  
Interest-bearing liabilities  1,662 1,448 0.0 0.0 0.0  
Balance sheet total (assets)  5,770 6,398 10,005 7,050 6,827  
Net Debt  1,662 1,448 0.0 0.0 0.0  
 
See the entire balance sheet

Volume 
2019
2020/3
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  4,867 5,724 8,076 4,476 4,429  
Gross profit growth  -4.3% 17.6% 41.1% -44.6% -1.0%  
Employees  5 5 5 6 6  
Employee growth %  0.0% 0.0% 0.0% 20.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  5,770 6,398 10,005 7,050 6,827  
Balance sheet change%  -10.7% 10.9% 56.4% -29.5% -3.2%  
Added value  789.3 468.2 4,589.6 338.6 63.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -38 -71 -10 -109 23  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 4.0 5.0 5.0  

Profitability 
2019
2020/3
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  15.1% 7.3% 56.2% 6.3% 0.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  11.8% 6.9% 55.3% 3.3% 0.5%  
ROI %  20.7% 17.6% 134.7% 6.4% 0.8%  
ROE %  16.7% 65.2% 145.3% 10.1% -3.0%  

Solidity 
2019
2020/3
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
Equity ratio %  8.5% 10.5% 42.0% 66.0% 66.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  210.6% 309.4% 0.0% 0.0% 0.0%  
Gearing %  491.4% 217.6% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/3
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
Quick Ratio  1.3 1.0 1.5 2.3 2.2  
Current Ratio  1.1 1.2 1.7 2.9 2.9  
Cash and cash equivalent  0.0 0.0 0.0 0.0 0.0  

Capital use efficiency 
2019
2020/3
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  433.1 953.5 4,023.1 4,530.9 4,407.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/3
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
Net sales / employee  0 0 0 0 0  
Added value / employee  158 94 918 56 11  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  158 94 918 54 11  
EBIT / employee  147 84 907 47 6  
Net earnings / employee  114 65 707 75 -23